title: Autologous HSCT for systemic sclerosis - Authors' reply.
authors.forename: Richard K
authors.initials: RK
authors.lastname: Burt
authors.forename: Sanjiv J
authors.initials: SJ
authors.lastname: Shah
authors.forename: James
authors.initials: J
authors.lastname: Schroeder
authors.forename: Maria Carolina
authors.initials: MC
authors.lastname: Oliveira
authors.forename: Daniela A
authors.initials: DA
authors.lastname: Moraes
authors.forename: Belinda
authors.initials: B
authors.lastname: Simoes
authors.forename: Zora
authors.initials: Z
authors.lastname: Marjanovic
authors.forename: Dominique
authors.initials: D
authors.lastname: Farge
mesh_terms: D002423:Cause of Death; D005260:Female; D006333:Heart Failure / Q000401:mortality*; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods* / Q000401:mortality*; D006801:Humans; D008297:Male; D010494:Pericarditis, Constrictive / Q000401:mortality*; D036102:Peripheral Blood Stem Cell Transplantation / Q000379:methods* / Q000401:mortality*; D045743:Scleroderma, Diffuse / Q000401:mortality* / Q000628:therapy*; D045745:Scleroderma, Limited / Q000401:mortality* / Q000628:therapy*; D018805:Sepsis / Q000401:mortality*; D019172:Transplantation Conditioning